CClinicalTrials.gg
Sign In
CompletedNCT04543084Updated Sep 1, 2023

Home Program Practice for People With Language Disorders After Stroke

An interventional study of Logbook in Aphasia and Stroke, sponsored by Duquesne University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-09-01.

Sponsored by Duquesne University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
7
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Logbooks are one of the most commonly used methods to both support and track adherence in research studies. This study will look at using logbooks to support adherence to reading practice for individuals with post-stroke aphasia. It is thought that using a logbook will increase practice time.

02

Conditions studied

  • Aphasia
  • Stroke
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 7 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Duquesne University is the lead sponsor of 26 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • at least 6 months post left hemisphere stroke with a diagnosis of aphasia
  • must have self-reported interest in working to improve reading comprehension
  • access to the Internet
  • speak English as a primary language

Exclusion criteria

Exclusion Criteria:

  • significant visual or hearing impairment as determined by "aphasia-friendly" and age-appropriate screening
  • actively receiving speech-language pathology services in which computerized or reading comprehension home practice activities are assigned/requested
  • severe auditory comprehension impairment that limits understanding of one-step directions (i.e., Western Aphasia Battery-Revised sequential commands subtest score below 8).
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
7 participants (actual)

Study arms

  • Other
    Single-Subject Design

    Each participant will go through a baseline phase and then an intervention phase.

    Behavioral: Logbook

Interventions

  • BehavioralLogbook

    Participants will record practice in a logbook.

06

What researchers measure

Primary outcomes

  1. Change in minutes of practice

    The number of minutes practiced

    Time frame: Up to 11 weeks

  2. Change in percentage of adherence to practice goal

    The amount of practice compared to the goal

    Time frame: Up to 11 weeks

Secondary outcomes

  1. Reading comprehension

    As measured by performance on the Reading Comprehension Battery for Aphasia-2 (RCBA-2). A higher score is better.

    Time frame: At first session and at last session time in between up to 5 months

07

Study locations

1 site
  • Duquesne University
    Pittsburgh, Pennsylvania 15228, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 1, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04543084
Lead sponsor
Duquesne University
Responsible party
Sponsor
First posted
Sep 9, 2020
Start date
Jan 22, 2021
Primary completion
Sep 6, 2022
Completion
Sep 6, 2022
Last update
Sep 1, 2023

Study contacts

Elena V. Donoso Brown, PhD
principal investigator · Duquesne University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Stroke→

Other studies from this sponsor

Duquesne University

Start the discussion